LEARNING OBJECTIVES:

• To do describe how novel developments in genetic therapy can be used to improve visual outcomes and visual quality of life in patients with inherited retinal dystrophies and degenerative disorders.
• To identify and describe emerging data evaluating the risk of maculopathy with the use of systemic pentosan polysulfate and integrate proposed guidelines for risk mitigation into clinical practice.

CANMEDS ROLES: Medical Expert, Scholar